Hong Kong · Delayed Price · Currency is HKD Kingworld Medicines Group Statistics
Total Valuation
HKG:1110 has a market cap or net worth of HKD 341.97 million. The enterprise value is 629.30 million.
| Market Cap | 341.97M |
| Enterprise Value | 629.30M |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Jun 5, 2025 |
Share Statistics
HKG:1110 has 589.60 million shares outstanding. The number of shares has decreased by -3.99% in one year.
| Current Share Class | 589.60M |
| Shares Outstanding | 589.60M |
| Shares Change (YoY) | -3.99% |
| Shares Change (QoQ) | +2.40% |
| Owned by Insiders (%) | 70.69% |
| Owned by Institutions (%) | 5.12% |
| Float | 139.91M |
Valuation Ratios
The trailing PE ratio is 55.35.
| PE Ratio | 55.35 |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| PB Ratio | 0.45 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.55, with an EV/FCF ratio of -9.15.
| EV / Earnings | 105.78 |
| EV / Sales | 0.61 |
| EV / EBITDA | 6.55 |
| EV / EBIT | 8.78 |
| EV / FCF | -9.15 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.14 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 6.26 |
| Debt / FCF | -6.92 |
| Interest Coverage | 3.91 |
Financial Efficiency
Return on equity (ROE) is 5.53% and return on invested capital (ROIC) is 4.01%.
| Return on Equity (ROE) | 5.53% |
| Return on Assets (ROA) | 2.02% |
| Return on Invested Capital (ROIC) | 4.01% |
| Return on Capital Employed (ROCE) | 5.30% |
| Weighted Average Cost of Capital (WACC) | 5.38% |
| Revenue Per Employee | 1.36M |
| Profits Per Employee | 7,838 |
| Employee Count | 759 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 6.10 |
Taxes
In the past 12 months, HKG:1110 has paid 14.95 million in taxes.
| Income Tax | 14.95M |
| Effective Tax Rate | 25.30% |
Stock Price Statistics
The stock price has increased by +35.63% in the last 52 weeks. The beta is 1.04, so HKG:1110's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +35.63% |
| 50-Day Moving Average | 0.53 |
| 200-Day Moving Average | 0.54 |
| Relative Strength Index (RSI) | 70.06 |
| Average Volume (20 Days) | 1,129,800 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1110 had revenue of HKD 1.03 billion and earned 5.95 million in profits. Earnings per share was 0.01.
| Revenue | 1.03B |
| Gross Profit | 257.76M |
| Operating Income | 51.66M |
| Pretax Income | 59.09M |
| Net Income | 5.95M |
| EBITDA | 66.63M |
| EBIT | 51.66M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 279.26 million in cash and 476.09 million in debt, with a net cash position of -196.83 million or -0.33 per share.
| Cash & Cash Equivalents | 279.26M |
| Total Debt | 476.09M |
| Net Cash | -196.83M |
| Net Cash Per Share | -0.33 |
| Equity (Book Value) | 765.96M |
| Book Value Per Share | 1.15 |
| Working Capital | 80.07M |
Cash Flow
In the last 12 months, operating cash flow was -23.73 million and capital expenditures -45.03 million, giving a free cash flow of -68.76 million.
| Operating Cash Flow | -23.73M |
| Capital Expenditures | -45.03M |
| Free Cash Flow | -68.76M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 25.03%, with operating and profit margins of 5.02% and 0.58%.
| Gross Margin | 25.03% |
| Operating Margin | 5.02% |
| Pretax Margin | 5.74% |
| Profit Margin | 0.58% |
| EBITDA Margin | 6.47% |
| EBIT Margin | 5.02% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 5.37%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 5.37% |
| Dividend Growth (YoY) | -6.21% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 364.34% |
| Buyback Yield | 3.99% |
| Shareholder Yield | 9.27% |
| Earnings Yield | 1.74% |
| FCF Yield | -20.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1110 has an Altman Z-Score of 1.57 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 3 |